10 likes | 12 Views
According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers. Owing to the benefits, such as inherent safety and ease-of-use, and provisions to reduce dosing errors, risk of occlusions, extravasation and phlebitis, several injectable drugs (Humirau00ae, Enbrelu00ae, Avastinu00ae, PREVNAR 13u00ae, ALPROLIXu00ae and Benefixu00ae), diluents and other products requiring parenteral administration, are packaged in prefilled syringes.<br> <br>To order this 260 page report, which features 60 figures and 110 tables, please visit this https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html<br><br>Contact Details<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>gaurav.chaudhary@rootsanalysis.com <br><br>
E N D